Extension Agreement to Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis

Summary

Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis have agreed to extend their existing agreement, originally dated January 2, 2014, through June 30, 2017. This document serves as written confirmation of the extension, with both parties acknowledging and agreeing to the new end date. No other terms of the original agreement are changed by this extension.

EX-10.14 2 t1700098_ex10-14.htm EXHIBIT 10.14

 

Exhibit 10.14

 

CYCLACEL PHARMACEUTICALS, INC.

200 Connell Drive, Suite 1500

Berkeley Heights, NJ 07922

 

December 22, 2016

 

Mr. Spiro Rombotis

c/o Cyclacel Pharmaceuticals, Inc.

200 Connell Drive, Suite 1500

Berkeley Heights, NJ 07922

 

Dear Mr. Rombotis:

 

Reference is made to the agreement between us (the “Agreement”) made as of January 2, 2014. This will confirm our agreement to extend the Agreement through the period ended June 30, 2017. Please confirm your agreement to the foregoing by signing below in the space provided.

 

  Sincerely,
   
  CYCLACEL PHARMACEUTICALS, INC.
     
  By: /s/ Paul McBarron
  Name: Paul McBarron
  Title: EVP, Finance & COO

 

ACKNOWLEDGED AND AGREED:  
   
/s/ Spiro Rombotis  
Spiro Rombotis